These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Circulating miR-99a-5p Expression in Plasma: A Potential Biomarker for Early Diagnosis of Breast Cancer. Garrido-Cano I, Constâncio V, Adam-Artigues A, Lameirinhas A, Simón S, Ortega B, Martínez MT, Hernando C, Bermejo B, Lluch A, Lopes P, Henrique R, Jerónimo C, Cejalvo JM, Eroles P. Int J Mol Sci; 2020 Oct 08; 21(19):. PubMed ID: 33050096 [Abstract] [Full Text] [Related]
15. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer. Bae SY, Kim S, Lee JH, Lee HC, Lee SK, Kil WH, Kim SW, Lee JE, Nam SJ. BMC Cancer; 2015 Mar 18; 15():138. PubMed ID: 25880075 [Abstract] [Full Text] [Related]
18. Identification of circulating microRNA signatures for breast cancer detection. Chan M, Liaw CS, Ji SM, Tan HH, Wong CY, Thike AA, Tan PH, Ho GH, Lee AS. Clin Cancer Res; 2013 Aug 15; 19(16):4477-87. PubMed ID: 23797906 [Abstract] [Full Text] [Related]
19. Serum microRNA-21 expression as a prognostic and therapeutic biomarker for breast cancer patients. Yadav P, Mirza M, Nandi K, Jain SK, Kaza RC, Khurana N, Ray PC, Saxena A. Tumour Biol; 2016 Nov 15; 37(11):15275-15282. PubMed ID: 27696295 [Abstract] [Full Text] [Related]